StockData
Merck & Co., Inc. logo

Merck & Co., Inc. (MRK) stock

MRKNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 9/30240% above fair value
$143.37−1.09 (-0.75%)

Close on Nov 17, 2026Market cap $353.72BP/E 114.7Yield 2.29%

Merck pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

Merck's pe ratio was 118.4× on Nov 10, 2026, against 13.8× a year earlier. Over the last 5 years it ranged from 11.2× to 942.5×, with a median of 20.2×.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 10, 2026118.4×+104.5
2025Dec 31, 202513.9×−7.0
2024Dec 31, 202420.9×−39.7
2023Dec 29, 202360.6×+42.1
2022Dec 30, 202218.5×−8.5
2021Dec 31, 202127.0×+8.9
2020Dec 31, 202018.1×−7.3
2019Dec 31, 201925.4×−35.7
2018Dec 31, 201861.1×+7.0
2017Dec 29, 201754.1×+24.1
2016Dec 30, 201630.0×+15.9
2015Dec 31, 201514.1×−24.5
2014Dec 31, 201438.6×+14.5
2013Dec 31, 201324.2×+5.5
2012Dec 31, 201218.7×+6.8
2011Jan 31, 201111.9×−1.0
2010Dec 31, 201013.0×–

More Merck figures

See a number that looks wrong?